Illumina Files 8-K on Operations and Financials
Ticker: ILMN · Form: 8-K · Filed: Feb 6, 2025 · CIK: 1110803
| Field | Detail |
|---|---|
| Company | Illumina, INC. (ILMN) |
| Form Type | 8-K |
| Filed Date | Feb 6, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations
Related Tickers: ILMN
TL;DR
Illumina dropped an 8-K on Feb 6th covering ops and financials - check it for the deets.
AI Summary
On February 6, 2025, Illumina, Inc. filed an 8-K report to disclose information regarding its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details beyond the reporting of these categories.
Why It Matters
This filing indicates Illumina is providing updates on its financial performance and condition, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for reporting operational and financial information, not indicating any immediate adverse events.
Key Players & Entities
- Illumina, Inc. (company) — Registrant
- February 6, 2025 (date) — Date of earliest event reported
FAQ
What specific financial results or operational details are disclosed in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not provide specific figures or details within the provided text.
What is the filing date of this 8-K report?
The filing date is February 6, 2025.
What is Illumina, Inc.'s principal executive office address?
Illumina, Inc.'s principal executive offices are located at 5200 Illumina Way, San Diego, CA 92122.
What is the Commission File Number for Illumina, Inc.?
The Commission File Number for Illumina, Inc. is 001-35406.
What is the Standard Industrial Classification (SIC) code for Illumina, Inc.?
The SIC code for Illumina, Inc. is 3826, which corresponds to Laboratory Analytical Instruments.
Filing Stats: 580 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-02-06 16:11:19
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value ILMN The Nasdaq Stock Market
Filing Documents
- ilmn-20250206.htm (8-K) — 29KB
- a4q24earningsrelease.htm (EX-99.1) — 892KB
- ilmn-20250206_g1.jpg (GRAPHIC) — 7KB
- image1.jpg (GRAPHIC) — 7KB
- 0001110803-25-000014.txt ( ) — 1114KB
- ilmn-20250206.xsd (EX-101.SCH) — 2KB
- ilmn-20250206_lab.xml (EX-101.LAB) — 21KB
- ilmn-20250206_pre.xml (EX-101.PRE) — 12KB
- ilmn-20250206_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
SIGNATURES
SIGNATURES Exhibit Index Table of Contents
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On February 6, 2025, Illumina, Inc. (the "Company") issued a press release announcing financial results for the fourth quarter and fiscal year ended December 29, 2024. The full text of the Company's press release is attached hereto as Exhibit 99.1. The information furnished pursuant to this Item 2.02 (including Exhibit 99.1) shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act. Table of Contents
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. 99.1 Press release dated February 6, 2025, announcing Illumina, Inc.'s financial results for the fourth quarter and fiscal year ended December 29, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) Table of Contents
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ILLUMINA, INC. Date: February 6, 2025 By: /s/ ANKUR DHINGRA Name: Ankur Dhingra Title: Chief Financial Officer Table of Contents Exhibit Index Exhibit Number Description 99.1 Press release dated February 6, 2025 announcing Illumina, Inc.'s financial results for the fourth quarter and fiscal year ended December 29, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)